Bezlotoxumab prevents extraintestinal organ damage induced by Clostridioides difficile infection. - Mileto SJ; Hutton ML; Walton SL; Das A; Ioannidis LJ; Ketagoda D; Quinn KM; Denton KM; Hansen DS; Lyras D (Gut microbes, 2022)